These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38369474)
21. Role of FGFR2-signaling in the pathogenesis of acne. Melnik BC Dermatoendocrinol; 2009 May; 1(3):141-56. PubMed ID: 20436882 [TBL] [Abstract][Full Text] [Related]
23. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo. Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251 [TBL] [Abstract][Full Text] [Related]
24. FGF2-labeled semiconductor nanocrystals as luminescent biolabels for imaging neuroblastoma cells. Xu G; Yong KT; Roy I; Kopwitthaya A J Biomed Nanotechnol; 2010 Dec; 6(6):641-7. PubMed ID: 21361128 [TBL] [Abstract][Full Text] [Related]
25. Glucose tolerance in obese men is associated with dysregulation of some angiogenesis-related gene expressions in subcutaneous adipose tissue. Minchenko OH; Bashta YM; Minchenko DO; Ratushna OO Fiziol Zh (1994); 2016; 62(2):12-23. PubMed ID: 29537219 [TBL] [Abstract][Full Text] [Related]
26. Effect of basic fibroblast growth factor (FGF2) on cumulus cell expansion, in vitro embryo production and gene expression in buffalo (Bubalus bubalis). Kumar S; Singla SK; Manik R; Palta P; Chauhan MS Reprod Biol; 2020 Dec; 20(4):501-511. PubMed ID: 32921625 [TBL] [Abstract][Full Text] [Related]
27. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389 [TBL] [Abstract][Full Text] [Related]
28. Effective treatment of acne scars using pneumatic injection of hyaluronic acid. Patel T; Tevet O J Drugs Dermatol; 2015 Jan; 14(1):74-6. PubMed ID: 25607911 [TBL] [Abstract][Full Text] [Related]
30. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides. Śmiłowicz D; Slootweg JC; Metzler-Nolte N Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097 [TBL] [Abstract][Full Text] [Related]
31. The modified tower vertical filler technique for the treatment of post-acne scarring. Goodman GJ; Van Den Broek A Australas J Dermatol; 2016 Feb; 57(1):19-23. PubMed ID: 26820783 [TBL] [Abstract][Full Text] [Related]
38. Evaluation and comparison of the efficacy and safety of cross-linked and non-cross-linked hyaluronic acid in combination with botulinum toxin type A in the treatment of atrophic acne scars: A double-blind randomized clinical trial. Behrangi E; Dehghani A; Sheikhzadeh F; Goodarzi A; Roohaninasab M Skin Res Technol; 2024 Jan; 30(1):e13541. PubMed ID: 38174839 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Acne Scar Treatment With Nonanimal Stabilized Hyaluronic Acid Gel. Dierickx C; Larsson MK; Blomster S Dermatol Surg; 2018 Nov; 44 Suppl 1():S10-S18. PubMed ID: 30358630 [TBL] [Abstract][Full Text] [Related]
40. Treatment of a traumatic atrophic depressed scar with hyaluronic acid fillers: a case report. Hussain SN; Goodman GJ; Rahman E Clin Cosmet Investig Dermatol; 2017; 10():285-287. PubMed ID: 28814892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]